For decades, the ritual of managing diabetes has been defined by the sharp sting of the lancet. In Egypt, where millions live with the condition, this daily necessity often requires ten punctures to the fingertips every single day, turning a medical requirement into a source of physical and psychological exhaustion. Dr. Sultan looked at the microscopic geography of the human skin and saw a different path: the stratum corneum, a protective layer of dead cells just 30 micrometers thick, which guards the body’s interstitial fluid.
His device does not seek blood. Instead, the polymer microneedles sip the fluid that surrounds the cells, a substance that carries the chemical secrets of the body’s metabolism without triggering the pain receptors located deeper in the dermis. This fluid contains roughly 40 percent of the water in the human body, providing a rich, steady stream of data that far exceeds what a single drop of blood can reveal in a moment of time.
By integrating Artificial Intelligence and the Internet of Things, the wearable monitors glucose, pulse, and temperature simultaneously. It is a self-contained system that does not merely record data but predicts the onset of a crisis before the patient feels a single symptom. The flexibility of the low-cost substrate allows the patch to move with the patient, turning a medical instrument into a second, more perceptive skin.
The transition from a laboratory breakthrough to a clinical tool is a journey of meticulous documentation. Dr. Sultan has begun formal discussions with the Egyptian Drug Authority to move the device from the workbench to the pharmacy shelf. At Nile University, the focus remains on the human interface—a piece of technology that rests on the arm as lightly as a breath, replacing the old, painful rhythm of the needle with the silent, constant vigilance of a machine.